Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Revenue (2019 - 2025)

Pulmonx (LUNG) has disclosed Revenue for 7 consecutive years, with $21.5 million as the latest value for Q3 2025.

  • Quarterly Revenue rose 5.47% to $21.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $91.7 million through Sep 2025, up 15.59% year-over-year, with the annual reading at $83.8 million for FY2024, 22.01% up from the prior year.
  • Revenue for Q3 2025 was $21.5 million at Pulmonx, down from $23.9 million in the prior quarter.
  • The five-year high for Revenue was $23.9 million in Q2 2025, with the low at $9.2 million in Q1 2021.
  • Average Revenue over 5 years is $17.0 million, with a median of $17.2 million recorded in 2023.
  • The sharpest move saw Revenue surged 232.24% in 2021, then rose 1.82% in 2022.
  • Over 5 years, Revenue stood at $13.7 million in 2021, then rose by 12.53% to $15.4 million in 2022, then grew by 24.98% to $19.3 million in 2023, then rose by 23.28% to $23.8 million in 2024, then decreased by 9.52% to $21.5 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $21.5 million, $23.9 million, and $22.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.